In the present study, univariate survival analysis revealed that clinical stage, LN metastasis, Her2 expression level and Mortalin expression status are all significantly related with DFS and OS rates of patients with breast cancer (P < 0.05). The gene discussed is ERBB2; the disease is breast carcinoma.